Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    savita thakur thakur
    savita thakur thakur
      • Home
      • savita thakur thakur

      Articles By : savita thakur thakur

      Fujifilm to launch Next Gen Echocardiography Machine

      Fujifilm to launch Next Gen Echocardiography Machine

      savita thakur thakur20 March 2016 10:27 AM IST
      Stamford : Fujifilim Medical Systems U.S.A., Inc., will demonstrate the next generation of echocardiography, cardiac cath image management and...
      OyeHelp launches mobile app for doctors, clinics and hospitals

      OyeHelp launches mobile app for doctors, clinics and hospitals

      savita thakur thakur20 March 2016 10:27 AM IST
      Panaji: Digital health technology company OyeHelp has come up with a smartphone app, which will act as a virtual interface, for doctors, clinics and...
      Bayer wins USFDA approval for hemophilia A therapy

      Bayer wins USFDA approval for hemophilia A therapy

      savita thakur thakur20 March 2016 10:23 AM IST
      The U.S. Food and Drug Administration approved Bayer AG's therapy for the most common form hemophilia, the company said on Thursday, about three weeks...
      Johnson & Johnson hit with $500 million verdict in hip implant trial

      Johnson & Johnson hit with $500 million verdict in hip implant trial

      savita thakur thakur20 March 2016 10:22 AM IST
      Johnson & Johnson (JNJ.N) and its DePuy unit were ordered by a Texas federal jury to pay about $500 million to five plaintiffs who said they were...
      Pfizer appoints S Sridhar as Managing Director

      Pfizer appoints S Sridhar as Managing Director

      savita thakur thakur20 March 2016 10:22 AM IST
      New Delhi : Pharmaceutical major Pfizer BSE -2.01 % appointed S Sridhar as its new Managing Director (MD) with immediate effect for a period of five...
      Aurobindo gets USFDA nod for Dexmedetomidine Hydrochloride injections

      Aurobindo gets USFDA nod for Dexmedetomidine Hydrochloride injections

      savita thakur thakur19 March 2016 4:08 PM IST
      New Delhi: Aurobindo Pharma has received final approval from the USFDA to manufacture and market pre- surgery sedation injections Dexmedetomidine...
      Torrent Pharma gets a nod from USFDA

      Torrent Pharma gets a nod from USFDA

      savita thakur thakur19 March 2016 11:33 AM IST
      New Delhi : Drug firm Torrent Pharma said its third manufacturing plant in Gujarat has obtained the Establishment Inspection Report (EIR) from the US...
      Glenmark gets tentative nod from USFDA for epilepsy drug

      Glenmark gets tentative nod from USFDA for epilepsy drug

      savita thakur thakur19 March 2016 11:27 AM IST
      New Delhi : Glenmark Pharmaceuticals said it has received tentative approval from the US health regulator for its generic version of Vimpat Oral...
      Pfizers Xeljanz meets goals in ulcerative colitis trials

      Pfizers Xeljanz meets goals in ulcerative colitis trials

      savita thakur thakur19 March 2016 11:24 AM IST
      Pfizer Inc said on Friday its Xeljanz rheumatoid arthritis drug succeeded in meeting primary and secondary goals of a pair of late stage clinical...
      Delhi HC stays ban on drugs of Wockhardt, Glaxo and Griffon

      Delhi HC stays ban on drugs of Wockhardt, Glaxo and Griffon

      savita thakur thakur19 March 2016 11:22 AM IST
      New Delhi: Delhi High Court stayed the the ban on some fixed dose combination (FDC) drugs of Glaxo SmithKline, Wockhardt and Laboratories Griffon but...
      Exploring all options to deal with drug ban: Merck

      Exploring all options to deal with drug ban: Merck

      savita thakur thakur19 March 2016 11:21 AM IST
      New Delhi: Drug major Merck Ltd said it is exploring all options to counter the ban on its two cough syrups, Cosome Expectorant and Cosome LCD,...
      Novartis Healthcare launches psoriasis treatment drug in India

      Novartis Healthcare launches psoriasis treatment drug in India

      savita thakur thakur18 March 2016 11:19 AM IST
      New Delhi: Novartis Healthcare has launched secukinumab, used for the treatment of plaque psoriasis in adult patients, in India.The company has...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok